Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Edelstein

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
AIDS Research and Human Retroviruses|August 20, 2009
Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphomaLeonard C Edelstein, Sophia Micheva-Viteva, Bradley D Phelan, et al.
Biochemistry|May 4, 1976
Isolation and characterization of a dog serum lipoprotein having apolipoprotein A-I as its predominant protein constituentC Edelstein, L L Lewis, J R Shainoff, et al.
Eye (London, England)|April 1, 2006
Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal studyS A Callejo, E Antecka, P L Blanco, et al.
The Journal of Biological Chemistry|December 25, 1984
Human proapolipoprotein A-II is cleaved following secretion from Hep G2 cells by a thiol proteaseJ I Gordon, H F Sims, C Edelstein, et al.
The Journal of Biological Chemistry|November 25, 1985
Extracellular processing of proapolipoprotein A-II in Hep G2 cell cultures is mediated by a 54-kDa protease immunologically related to cathepsin BJ I Gordon, H F Sims, C Edelstein, et al.
Plos Computational Biology|July 22, 2020
Bayesian modelling of high-throughput sequencing assays with malacodaAndrew R Ghazi, Xianguo Kong, Ed S Chen, et al.
Controlled Clinical Trials|August 1, 1993
Research cost analyses to aid in decision making in the conduct of a large prevention trial, CARET. Carotene and Retinol Efficacy TrialM D Thornquist, N Urban, A Tseng, et al.
Clinical Genetics|March 31, 1998
Lipoprotein(a): identification of subjects with a superbinding capacity for fibrinogenA M Scanu, M M Atzeni, C Edelstein, et al.
Thrombosis Research|March 26, 2021
PCTP contributes to human platelet activation by enhancing dense granule secretionShaji Abraham, Lin Ma, Xianguo Kong, et al.
Contraception|August 1, 1990
Single dose long-term suppression of testosterone secretion by a gonadotropin-releasing hormone antagonist (Antide) in male monkeysM C Edelstein, K Gordon, R F Williams, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
AIDS Research and Human Retroviruses|August 20, 2009
Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphomaLeonard C Edelstein, Sophia Micheva-Viteva, Bradley D Phelan, et al.
Biochemistry|May 4, 1976
Isolation and characterization of a dog serum lipoprotein having apolipoprotein A-I as its predominant protein constituentC Edelstein, L L Lewis, J R Shainoff, et al.
Eye (London, England)|April 1, 2006
Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal studyS A Callejo, E Antecka, P L Blanco, et al.
The Journal of Biological Chemistry|December 25, 1984
Human proapolipoprotein A-II is cleaved following secretion from Hep G2 cells by a thiol proteaseJ I Gordon, H F Sims, C Edelstein, et al.
The Journal of Biological Chemistry|November 25, 1985
Extracellular processing of proapolipoprotein A-II in Hep G2 cell cultures is mediated by a 54-kDa protease immunologically related to cathepsin BJ I Gordon, H F Sims, C Edelstein, et al.
Plos Computational Biology|July 22, 2020
Bayesian modelling of high-throughput sequencing assays with malacodaAndrew R Ghazi, Xianguo Kong, Ed S Chen, et al.
Controlled Clinical Trials|August 1, 1993
Research cost analyses to aid in decision making in the conduct of a large prevention trial, CARET. Carotene and Retinol Efficacy TrialM D Thornquist, N Urban, A Tseng, et al.
Clinical Genetics|March 31, 1998
Lipoprotein(a): identification of subjects with a superbinding capacity for fibrinogenA M Scanu, M M Atzeni, C Edelstein, et al.
Thrombosis Research|March 26, 2021
PCTP contributes to human platelet activation by enhancing dense granule secretionShaji Abraham, Lin Ma, Xianguo Kong, et al.
Contraception|August 1, 1990
Single dose long-term suppression of testosterone secretion by a gonadotropin-releasing hormone antagonist (Antide) in male monkeysM C Edelstein, K Gordon, R F Williams, et al.
Pageof 12